Anna Ermacora
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
- Hematology 10
- Chronic Myeloid Leukemia Treatments 5
- Acute Myeloid Leukemia Research 3
- Oncology 11
- Drug Transport and Resistance Mechanisms 11
- Co-authors
- Michele Baccarani (13 shared papers)Mariagrazia Michieli (16 shared papers)Daniela Damiani (15 shared papers)Paola Masolini (7 shared papers)Angela Michelutti (8 shared papers)Domenico Russo (9 shared papers)Donatella Raspadori (3 shared papers)Renato Fanin (10 shared papers)
- Journals
- British Journal of Haematology (5 papers)Hematological Oncology (4 papers)HemaSphere (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)Blood (1 paper)
- Partner nations
- ItalyUnited StatesNetherlands
In The Last Decade
Anna Ermacora
31 papers receiving 653 citations
Peers
Comparison fields: 5 of 38
- Hematology 200
- Oncology 238
- Hepatology 43
- Biomaterials 39
- Surgery 75
Countries citing papers authored by Anna Ermacora
This map shows the geographic impact of Anna Ermacora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ermacora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ermacora more than expected).
Fields of papers citing papers by Anna Ermacora
This network shows the impact of papers produced by Anna Ermacora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ermacora. The network helps show where Anna Ermacora may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Ermacora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 103 | |
| 2 | 1999 | 76 | |
| 3 | 1997 | 63 | |
| 4 | Rituximab for the treatment of type II mixed cryoglobulinemia. | 1999 | 47 |
| 5 | 1999 | 46 | |
| 6 | 2000 | 42 | |
| 7 | 2002 | 33 | |
| 8 | P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias. | 1998 | 32 |
| 9 | 2018 | 32 | |
| 10 | Effect of fludarabine and arabinosylcytosine on multidrug resistant cells. | 1997 | 25 |
| 11 | 2000 | 23 | |
| 12 | 2019 | 23 | |
| 13 | 1998 | 18 | |
| 14 | 1999 | 18 | |
| 15 | Liposome encapsulated daunorubicin (daunoxome) for acute leukemia. | 2000 | 13 |
| 16 | 2016 | 11 | |
| 17 | 2012 | 10 | |
| 18 | 2022 | 9 | |
| 19 | Lamivudine for the prevention of hepatitis B virus reactivation during autologous stem cell transplantation. A case report. | 2000 | 8 |
| 20 | Overcoming PGP-related multidrug resistance. The cyclosporine derivative SDZ PSC 833 can abolish the resistance to methoxy-morpholynil-doxorubicin. | 1996 | 7 |
About Anna Ermacora
Anna Ermacora is a scholar working on Hematology, Oncology, Hepatology, Pathology and Forensic Medicine and Biomaterials, having authored 32 papers that have together received 677 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (11 papers), Chronic Myeloid Leukemia Treatments (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Acute Myeloid Leukemia Research (3 papers), Hepatitis C virus research (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Hepatitis B Virus Studies (2 papers) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Hematology (200 citations), Oncology (238 citations), Hepatology (43 citations), Biomaterials (39 citations) and Surgery (75 citations). Anna Ermacora has collaborated with scholars based in Italy, United States and Netherlands. Frequent co-authors include Michele Baccarani, Mariagrazia Michieli, Daniela Damiani, Paola Masolini, Angela Michelutti, Domenico Russo, Donatella Raspadori, Renato Fanin, Rik J. Scheper and Giuseppe Visani. Their work appears in journals such as British Journal of Haematology, Hematological Oncology, HemaSphere, Cancer Chemotherapy and Pharmacology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.